SVB Wealth LLC Sells 894 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

SVB Wealth LLC trimmed its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,520 shares of the medical instruments supplier’s stock after selling 894 shares during the quarter. SVB Wealth LLC’s holdings in DENTSPLY SIRONA were worth $695,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. VisionPoint Advisory Group LLC grew its position in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in shares of DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 568 shares during the period. Point72 Asset Management L.P. purchased a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $44,000. Anchor Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $47,000. Finally, Exchange Traded Concepts LLC increased its stake in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 439 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Up 0.2 %

Shares of XRAY stock opened at $30.50 on Friday. The business’s fifty day moving average is $32.79 and its 200 day moving average is $32.84. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $43.24. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. During the same period in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.10%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s payout ratio is -103.22%.

Analyst Ratings Changes

Several research firms have recently issued reports on XRAY. Piper Sandler boosted their target price on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research note on Friday, January 12th. SVB Leerink began coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 target price on the stock. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.